Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction

Current Pharmaceutical Design

Volumn 12, Issue 34, 2006, Pages 4501-4511

  Deniaud, Aurélien ^a   Hoebeke, Johan ^b   Briand, Jean Paul ^b   Muller, Sylviane ^b   Jacotot, Etienne ^c   Brenner, Catherine ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c Theraptosis SA   (France)

Author keywords

ATP cell content; Cancer; Inner mitochondrial membrane (IM); Ischemic reperfusion injury; Voltage dependent anion channel (VDAC)

Indexed keywords

MITOCHONDRIAL TRANSITION PORE COMPLEX; PERMEABILITY TRANSITION PORE COMPLEX; POLYPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VIRUS PROTEIN;

AGING; APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CYTOSOL; DEGENERATIVE DISEASE; HOMEOSTASIS; HUMAN; INTRACELLULAR SPACE; ISCHEMIA; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW;

AGING; ANIMALS; APOPTOSIS; DRUG DELIVERY SYSTEMS; HOMEOSTASIS; HUMANS; LIVER DISEASES; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PEPTIDES; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 33751543499     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206779010530     Document Type: Review

References (100)

1. Elmore S, Qian T, Grissom SF, Lemasters JJ. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J 2001; 15: 2286-7.
2. Hunter DR, Haworth R. A, Southard JH. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 1976; 251: 5069-77.
3. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627-37.
4. Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C, et al. Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ 2000; 7: 1146-54.
5. Belzacq AS, Vieira HL, Kroemer G, Brenner C. The adenine nucleotide translocator in apoptosis. Biochimie 2002; 84: 167-76.
6. Costantini P, Belzacq AS, Vieira HL, Larochette N, de Pablo MA, Zamzami N, et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000; 19: 307-14.
7. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, et al. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res 1999; 249: 413-21.
8. Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M, et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998; 241: 426-34.
9. Pfeiffer DR, Gudz TI, Novgorodov SA, Erdahl WL. The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition. J Biol Chem 1995; 270: 4923-4932.
10. Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000; 191: 33-46.
11. Vieira HL, Boya P, Cohen I, El Hamel C, Haouzi D, Druillenec S, et al. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L). Oncogene 2002; 21: 1963-77.
12. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM, Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 1997; 174: 167-72.
13. Clarke SJ, McStay GP, Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 2002; 277: 34793-9.
14. Halestrap AP, Brenner C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003; 10: 1507-25.
15. Shoshan-Barmatz V, Gincel D. The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem Biophys 2003; 39: 279-92.
16. Cassarino DS, Parks JK, Parker WD, Bennett JP. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1999; 1453: 49-62.
17. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 1999; 76: 725-34.
18. Lemasters JJ, Nieminen AL. Negative contrast imaging of mitochondria by confocal microscopy. Biophys J 1999; 77: 1747-50.
19. Lemasters JJ, Nieminen A, Qian T, Trost L, Herman B. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem 1997; 174: 159-65.
20. Nieminen AL, Byrne AM, Herman B, Lemasters JJ. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol 1997; 272: C1286-94.
21. Nieminen AL, Saylor AK, Tesfai SA, Herman B, Lemasters JJ. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J 1995; 307: 99-106.
22. Poncet, D Boya P, Metivier D, Zamzami N, Kroemer G. Cytofluorometric quantitation of apoptosis-driven inner mitochondrial membrane permeabilization. Apoptosis 2003; 8: 521-30.
23. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241: 139-76.
24. Zoratti M, Szabo I. Electrophysiology of the inner mitochondrial membrane. J Bioenerg Biomembr 1994; 26: 543-53.
25. Belzacq AS, Brenner C. The adenine nucleotide translocator: a new potential chemotherapeutic target. Curr Drug Targ 2003; 4: 517-24.
26. He L, Lemasters JJ. Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 2002; 512: 1-7.
27. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434: 658-62.
28. Nakagawa, T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434, 652-8.
29. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004; 427: 461-5.
30. Bouchier-Hayes L, Lartigue L, Newmeyer DD. Mitochondria: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2640-7.
31. Halestrap, A. Biochemistry: a pore way to die. Nature 2005; 434, 578-9.
32. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 1998; 187: 1261-71.
33. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa, F. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 2001; 276:12030-4.
34. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 789-99.
35. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-9.
36. Brenner C, Le Bras M, Kroemer G. Insights into the mitochondrial signaling pathway: what lessons for chemotherapy? J Clin Immunol 2003; 23: 73-80.
37. Faure Vigny H, Heddi A, Giraud S, Chautard D, Stepien G. Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines. Mol Carcinog 1996; 16: 165-72.
38. Sebastian S, Kenkare UW. Expression of two type II-like tumor hexokinase RNA transcripts in cancer cell lines. Tumor Biol 1998; 19: 253-260.
39. Maaser K, Grabowski P, Sutter A P, Hopfner M, Foss HD, Stein H, et al. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer. Clin Cancer Res 2002; 8: 3205-9.
40. Giusti L, Costa B, Viacava P, Castagna M, Lacconi P, Ricci RE, et al. Peripheral type benzodiazepine receptor in human parathyroid glands: up-regulation in adenoma. J Endocrinol Invest 2004; 27, 826-31.
41. Maaser K, Grabowski P, Oezdem Y, Krahn A, Heine B, Stein H, et al. H. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread. Clin Cancer Res 2005; 11: 1751-6.
42. Shinohara Y, Ishida T, Hino M, Yamazaki N, Baba Y, Terada H. Characterization of porin isoforms expressed in tumor cells. Eur J Biochem 2000; 267: 6067-73.
43. Shiio Y, Donohoe S, Yi EC, Goodlett D, Aebersold R, Eisenman RN. Quantitative proteomic analysis of Myc oncoproteins function. EMBO J 2002; 21: 5088-5096.
44. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 1998; 281: 409-18.
45. Warburg O. The origin of cancer cells. Science 1956; 123: 309-314.
46. Barath P, Luciakova K, Hodny Z, Li R, Nelson BD. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp Cell Res 1999; 248: 583-8.
47. Konopleva M, Zhao S, Hu W, Jiang S, Snell V, Weidner D, et al. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells. Br J Haematol 2002; 118: 521-34.
48. Kitada S, Pedersen IM, Schimmer AD, Reed JC. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 2002; 21: 3459-74.
49. Gascoyne RD, Krajewska M, Krajewski S, Connors JM, Reed JC. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997; 90: 3173-3178.
50. Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A, et al. The amount of spontaneous apoptosis detected by bax/ bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 101: 2125-31.
51. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, et al. G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-31.
52. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1: 233-40.
53. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 2000; 275: 16202-12.
54. Schuler M, Green DR. Transcription, apoptosis and p53: catch-22. Trends Genet 2005; 21: 182-7.
55. Chipuk JE, Green DR. Cytoplasmic p53: bax and forward. Cell Cycle 2004, 3, 429-31.
56. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005; 6: 268-75.
57. Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie 2002; 84: 153-66.
58. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssière JL, Petit PX, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo J Exp Med 1995; 181: 1661-1672.
59. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B, et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis FEBS Lett 1996; 384: 53-57.
60. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 1999; 147: 1493-502.
61. Lin DT, Lechleiter JD. Mitochondrial targeted cyclophilin D protects cells from Cell death by peptidyl prolyl isomerization. J Biol Chem 2002; 277: 31134-41.
62. Schubert A, Grimm S. Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res 2004; 64: 85-93.
63. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 2004; 39: 1533-43.
64. Belous A, Knox C, Nicoud IB, Pierce J, Anderson C, Pinson CW, Chari RS. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Transplantation 2003; 75: 1717-23.
65. Belous A, Knox C, Nicoud IB, Pierce J, Anderson C, Pinson CW, et al. Altered ATP-dependent mitochondrial Ca2+ uptake in cold ischemia is attenuated by ruthenium red. J Surg Res 2003; 111: 284-9.
66. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-73.
67. Haouzi D, Cohen I, Vieira HL, Poncet D, Boya P, Castedo M, et al. Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo. Apoptosis 2002; 7: 395-405.
68. Kon K, Kim JS, Jaeschke H, Lemasters JJ. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004; 40: 1170-9.
69. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 2002; 84: 241-50.
70. Khaspekov L, Friberg H, Halestrap A, Viktorov I, Wieloch T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur J Neurosci 1999; 11: 3194-8.
71. Friberg H, Connern C, Halestrap AP, Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J Neurochem 1999; 72: 2488-97.
72. Cassarino DS, Bennett JP. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev 1999; 29:1-25.
73. Nohl H, Kramer R. Molecular basis of age-dependent changes in the activity of adenine nucleotide translocase. Mech Ageing Dev 1980; 14: 137-44.
74. Nohl H. Age-dependent changes in the structure-function correlation of ADP/ATP-translocating mitochondrial membranes. Gerontology 1982; 28: 354-9.
75. Yan L, Sohal R. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 1998; 95: 12896-12901.
76. Paradies G, Ruggiero FM, Gadaleta MN, Quagliariello E. The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. Biochim Biophys Acta 1992; 1103: 324-6.
77. Paradies G, Ruggiero FM. Effect of aging on the activity of the phosphate carrier and on the lipid composition in rat liver mitochondria. Arch Biochem Biophys 1991; 284: 332-7.
78. Mather M, Rottenberg H. Effect of aging on the activity of the phosphate carrier and on the lipid composition in rat liver mitochondria. Biochem Biophys Res Commun 2000; 273: 603-8.
79. Petronilli V, Nicolli A, Costantini P, Colonna R, Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta 1994; 1187: 255-9.
80. Cao G, Minami M, Pei W, Yan C, Chen D, O'Horo C, et al. Intracellular bax translocation after transient cerebral ischemia: implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. J Cereb Blood Flow Metab 2001; 21: 321-33.
81. Sullivan PG, Thompson MB, Scheff SW. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999; 160: 226-234.
82. Feldmann G, Haouzi D, Moreau A, Durand-Schneider AM, Bringuier A, Berson A, et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 2000; 31: 674-83.
83. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997; 3: 614-20.
84. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
85. Brenner C, Marzo I, de Araujo Vieira HL, Kroemer G. Mitochondrial control of cell death. Methods Enzymol 2000; 322: 243-52.
86. Weaver JGR, Tarze A, Moffat TC, Le Bras M, Deniaud A, Brenner C, et al. Inhibition of Adenine Nucleotide Translocator Pore Function and Protection Against Apoptosis in vivo by an HIV Protease Inhibitor. J Clin Invest 2005; 115:1828-38.
87. Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillennec S, Hoebeke J, et al. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2. J Exp Med 2001; 193: 509-19.
88. Goldmacher VS. vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie 2002; 84: 177-85.
89. Shirakata Y, Koike KJ. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 2003; 278: 22071-8.
90. Chami M, Ferrari D, Paterlini-Brechot P, Rizzuto R. Caspase-dependent alterations of Ca2+ signaling in the induction of apoptosis by Hepatitis B virus X protein. J Biol Chem 2003; 278: 31745-55.
91. Everett H, Barry M, Sun X, Lee SF, Frantz C, Berthiaume LG, et al. The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore. J Exp Med 2002; 196: 1127-39.
92. Verrier F, Deniaud A, Lebras M, Metivier D, Kroemer G, Mignotte B, et al. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene 2004; 23: 8049-64.
93. Chaloin O, Peter JC, Briand JP, Masquida B, Desgranges C, Muller S, et al. The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci 2005; 62: 355-361.
94. Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, Trezeguet V, Lauquin GJ, Brandolin G. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 2003; 426: 39-44.
95. Fischer U, Schulze-Osthoff K. Apoptosis-based therapies and drug targets. Cell Death Differ 2005; 12: 942-61.
96. Garber K. New apoptosis drugs face critical test. Nat Biotechnol 2005; 23: 409-11.
97. Verrier F, Deniaud A, LeBras M, Metivier D, Kroemer G, Mignotte B, et al. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene 2004; 23: 8049-64.
98. Christophe M, Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Pharm Des 2006; 12(6): 739-57.
99. Plaetzer K, Kiesslich T, Oberdanner CB, Krammer B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr Pharm Des 2005; 11(9): 1151-65.
100. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS. The Voltage-Dependent Anion Channel (VDAC): Function in Intracellular Signalling, Cell Life and Cell Death. Curr Pharm Des 2006; 12(18): 2249-70.